Novo Nordisk A/S (NONOF)
38.50
+1.38
(+3.72%)
USD |
OTCM |
Mar 04, 12:59
Novo Nordisk Cash from Investing (TTM) : -12.34B for Dec. 31, 2025
Cash from Investing (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (TTM) Benchmarks
| Eli Lilly & Co. | -10.97B |
| Hims & Hers Health, Inc. | -1.025B |
| Genmab A/S | -5.660B |
| Ascendis Pharma A/S | -9.612M |